Mylicongas 40mg 50 Tablets

Milicon gas is a simethicone-based drug indicated for the symptomatic treatment of gastro-enteric meteorism and adult aerophagia.

Active principles
Each tablet contains: Active ingredient: simethicone (activated dimethylpolysiloxane) mg 40 For a full list of excipients, see 6.1

Excipients
Saccharin; Alginic acid; Lactose; Sodium bicarbonate; Povidone; Hydrated calcium silicate; Magnesium stearate

Contraindications
Hypersensitivity to the active substance or to any of the excipients. Generally contraindicated in pregnancy (see section 4.6).

Warnings
Do not exceed the recommended dose. After a short period of treatment without appreciable results, consult your doctor. The medicinal product contains lactose and is therefore not suitable for individuals with lactase deficiency, galactosemia or glucose / galactose malabsorption syndrome.

Pregnancy
Pregnancy. There are no adequate data on the use of MYLICONGAS in pregnant women, therefore it should not be used in pregnancy unless a real need and after a benefit / risk assessment by the physician. Feeding time. It is not known whether simethicone is excreted in human milk. The excretion of simethicone into breast milk has not been studied in animals. The decision whether to continue / discontinue breastfeeding or to continue / discontinue simethicone therapy should be made taking into account the benefit of breastfeeding for the infant and the benefit of simethicone therapy for the woman.

Side effects
No undesirable effects due to MYLICONGAS were highlighted.

Overdose
No overdose phenomena have been reported with the use of MYLICONGAS.

Interactions
No incompatibilities with other drugs are known, nor have they been reported.

storage
Keep the medicine in the original package to protect the product from light and moisture